Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.31 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.31 |
| ▸ | RAC2 | P15153 | 1/20 | 0.31 |
| ▸ | RAC3 | P60763 | 1/20 | 0.31 |
| ▸ | CDC42 | P60953 | 1/20 | 0.31 |
| ▸ | RAC1 | P63000 | 1/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20114171 | 0.99 | CHEK2 (0.31) | CHEK2RAC2RAC3CDC42RAC1 | |
| SCHEMBL20114779 | 0.92 | EDNRB (0.32) | CHEK2RAC2RAC3CDC42RAC1 | |
| SCHEMBL20114512 | 0.91 | EDNRA (0.34) | RAC2RAC3CDC42RAC1EDNRB | |
| SCHEMBL15944575 | 0.91 | EDNRA (0.34) | RAC2RAC3CDC42RAC1EDNRB | |
| SCHEMBL20114076 | 0.90 | PLA2G2A (0.34) | PLA2G2APLA2G4ARAC2RAC3CDC42 | |
| SCHEMBL20114221 | 0.90 | ALDH1A1 (0.35) | CHEK2 | |
| SCHEMBL20114357 | 0.89 | PTGER4 (0.32) | EDNRBEDNRA | |
| SCHEMBL20114072 | 0.89 | PTGER4 (0.32) | EDNRBEDNRA | |
| SCHEMBL20114796 | 0.89 | PTGER4 (0.32) | RAC2RAC3CDC42RAC1EDNRB | |
| SCHEMBL20114120 | 0.89 | PTGER4 (0.32) | RAC2RAC3CDC42RAC1EDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018080067-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING SAME | 주식회사 두산 | 2018-05-03 | — | — | WO | disclosed |